Biocytogen Pharmaceuticals Co. Ltd. (2315)
Market Closed
11 Aug, 08:00
HKEX 
67. 30
HKD -1.35
-1.9665%
2.33B Market Cap
- P/E Ratio
- Div Yield
3.32M Volume
- Eps
68.65 HKD
Previous Close Want to track 2315 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biocytogen Pharmaceuticals Co. Ltd. (2315) Statistics
Valuation metrics
Market Cap 2.33B
Enterprise value 20.54B
Trailing P/E (ttm) 123.06
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) 15.61
Price/Book (mrq) 9.76
Enterprise Value/Revenue 14.9
Enterprise Value/EBITDA 48.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.87M
Average volume (90 days) 1.61M
Price summary
52-Week low 20.3
52-Week high 75.3
Beta -
50-Day moving average 50.33
200-Day moving average 50.56
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 2.31%
Book value per share (mrq) 5.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
